Q2 Venture Investment Remains Down From A Year Ago
Venture capitalists invested $5.27 billion in 595 deals during the second quarter, a 32 percent improvement over the first quarter, but still much less than the $8.33 billion and 726 deals recorded during the second quarter of 2008, according to Dow Jones VentureSource.
In Central Massachusetts, only three deals were completed during the quarter, according to the data collected by Dow Jones.
Those deals were $20 million invested in Framingham medical device firm Interlace Medical, $1 million invested in May in now-defunct SiCortex, a Maynard-based software developer, and $8 million invested in Verax Biomedical, a Worcester-based medical device company.
During the quarter, health care investment topped IT for the first time on record as investors worked to diversify their portfolios.
Dow Jones said it has seen investors move away from traditional areas of interest like biopharmaceuticals and software toward medical devices and information services. At the same time, investors are "pulling back on how much they are willing to invest in each deal," Dow Jones said.
WBJ Web Partners
Most Recent
Most Recent
0 Comments